Platelet Inhibition After Glycoprotein IIb/IIIa Inhibitor Therapy

Circulation- United States

doi 10.1161/circ.104.25.e163

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Deaths Associated With Platelet Glycoprotein IIb/IIIa Inhibitor Treatment

Heart
2003English

Platelet Inhibition With an Antibody to Glycoprotein IIb/IIIa

Circulation
Cardiovascular MedicinePhysiologyCardiology
1989English

Platelet Glycoprotein IIb/IIIa Inhibition and Atheroembolism During Bypass Graft Angioplasty: A Cup Half Full

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2000English

Glycoprotein IIb/IIIa Induced Coronary Thrombolysis

Heart
2002English

Role of Platelet Membrane Glycoprotein IIb-IIIa in Agonist-Induced Tyrosine Phosphorylation of Platelet Proteins

Journal of Cell Biology
MedicineCell Biology
1990English

Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non-St-Elevation Acute Coronary Syndromes

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Comparative Efficacy of Fibrinogen and Platelet Supplementation on the in Vitro Reversibility of Competitive Glycoprotein IIb/IIIa (αIIb/β3) Receptor-Directed Platelet Inhibition

American Heart Journal
Cardiovascular MedicineCardiology
2001English

Off-Target Effects of Glycoprotein IIb/IIIa Receptor Inhibitors

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy